Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind Crossover Study to Evaluate the Safety and Efficacy of Adaptive Deep Brain Stimulation Delivered Through AlphaDBS System in Patients With Parkinson's Disease

NCT04681534 is registered in ClinicalTrials.gov with Newronika as lead sponsor.

NCT NCT04681534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04681534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind Crossover Study to Evaluate the Safety and Efficacy of Adaptive Deep Brain Stimulation Delivered Through AlphaDBS System in Patients With Parkinson's Disease
Lead sponsor
Newronika
Phase
Not applicable
Overall status
Unknown status
Start date
January 26, 2021
Completion date
December 30, 2025
Enrollment
15 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease